IP Library Granted Patent US 12,480,155
Granted Patent B2
US 12,480,155 · App. 17/618,949 · Granted Nov 25, 2025

Nicking enzymes

Inventors: Jarrod Provins (San Clemente, CA); Victor Perez (Imperial Beach, CA); Daiwei Shen (Vista, CA); Anthony Farina (Carlsbad, CA); Bryan Kraynack (La Jolla, CA)
Assignee: LumiraDx UK Ltd.
C12Q1/6844C12N9/22C12Q1/6848C12Q1/6851
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,480,155
App. No.
17/618,949
Granted
Nov 25, 2025
Kind
B2
Abstract

Disclosed is a composition comprising a nicking enzyme and a water-soluble rubidium salt, and a method of performing a reaction catalysed by a nicking enzyme including the presence of a water-soluble rubidium salt in the reaction.

Claims (24)

1 . A composition comprising a nicking enzyme and a water-soluble rubidium salt in an effective amount to improve the activity of the nicking enzyme.

2 . The composition according to claim 1 , wherein the rubidium salt is selected from the group consisting of: rubidium sulfate, a rubidium halide and rubidium nitrate.

3 . The composition according to claim 2 , wherein the rubidium halide is rubidium chloride.

4 . The composition according to claim 1 , wherein the nicking enzyme is selected from the group consisting of: Nb.BsmI, Nb.Bts, Nt.AlwI, Nt.BbvC, Nt.BstNBI and Nt.Bpu101.

5 . The composition according to claim 1 , provided in dry form.

6 . The composition according to claim 1 , provided as an aqueous solution.

7 . The composition according to claim 1 , further comprising a pH buffer substance.

8 . The composition according to claim 7 , wherein the pH buffer substance is selected from the group consisting of: Trishydrochloride, Tris hemisulfate, Tris EDTA, Tris Base, Tris EGTA, N,N-Bis(2-hydroxyethyl)glycine, N,N-Bis(2-hydroxyethyl)-3-amino-2-hydroxypropanesulfonic acid, 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid, N-(2-hydroxyethyl)piperazine-N′-(4-butanesulfonicacid),4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid, orthoboric acid, 3-(N-Morpholino)propanesulfonic acid hemisodium salt, 3-(N-Morpholino)propanesulfonic acid sodium salt, 3-(N-Morpholino)propanesulfonic acid, Piperazine-1,4-bis(2-hydroxypropanesulfonic acid) dihydrate, N-[Tris(hydroxymethyl)methyl]-3-aminopropanesulfonic acid, 3-(N-tris[hydroxymethyl]methylamino)-2-hydroxypropanesulfonic acid, N-[Tris(hydroxymethyl)methyl]glycine, sodium chloride, sodium sulfate, sodium acetate, sodium hydride, sodium nitrite, sodium nitrate, sodium borate, boric acid, potassium sulfate, potassium acetate, potassium borate, potassium chloride, potassium nitrite, potassium nitrate, magnesium sulfate, magnesium chloride, magnesium acetate, ammonium chloride, ammonium sulfate, ammonium acetate, ethylenediaminetetraacetic acid, ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid, citric acid, or a combination thereof.

9 . The composition according to claim 1 , comprising a carbohydrate.

10 . The composition according to claim 9 , wherein the carbohydrate is selected from the group consisting of: fructose, Ficoll®, hydroxyethyl (heta) starch, pentosan polysulfate, polyphosphoric acid, poly-L-glutamic acid, sucrose, trehalose, maltotriose, dextrans, mannitol, sorbitol, glucose, mannose, galactose, lactose, maltose, lactulose, raffinose, melezitose, 1,6-anhydroglucose, k-carrageenan, microcrystalline cellulose, polyethylene glycols, polyvinylpyrrolidone, leucrose, kestose, stachyose, verbascose, nystose, maltodextrin, cyclodextrins, isomaltooligosaccharide, fructooligosaccharides, inulin, or a combination thereof.

11 . The composition according claim 1 , wherein the composition is other than the composition or aqueous solution consisting of 12.5 mM MgSO 4 , 90 mM Tris-HCl (pH 8.5), 15 mM NH 4 CH 3 CO 2 , 15 mM Na 2 SO 4 , 5 mM DTT, 0.2 mg/ml BSA, 0.02% Triton X-100, 20 mM Rb 2 SO 4 , 10 mM L-threonine, and 0.008 U/μl nicking enzyme.

12 . The composition according to claim 1 , wherein the composition is other than a composition comprising 12.5 mM MgSO 4 , 90 mM Tris-HCl (pH 8.5), 15 mM NH 4 CH 3 CO 2 , 15 mM Na 2 SO 4 , 5 mM DTT, 0.2 mg/ml BSA, 0.02% Triton X-100, 20 mM Rb 2 SO 4 , 10 mM L-threonine, and 0.008 U/μl nicking enzyme in combination with one or more additional constituents.

13 . A kit for performing a nucleic acid amplification reaction, the kit comprising a package and, within the package, one or more aliquots of the composition according to claim 1 .

14 . A lateral flow or microfluidic device comprising a measured amount of the composition according to claim 1 .

15 . A method for performing a reaction catalysed by a nicking enzyme, the method comprising the step of contacting a nicking enzyme with a double stranded polynucleotide substrate having a recognition site for the nicking enzyme, in the presence of a water-soluble rubidium salt in an effective amount to improve the activity of the nicking enzyme, in aqueous conditions compatible with the nicking enzyme, so as to effect at least one single-stranded nick or cut in the double stranded polynucleotide substrate.

16 . The method according to claim 15 , wherein the single-stranded nick in the substrate is made in conditions other than in an aqueous solution comprising the following constituents at the recited concentration: 12.5 mM MgSO 4 , 90 mM Tris-HCl (pH 8.5), 15 mM NH 4 CH 3 CO 2 , 15 mM Na 2 SO 4 , 5 mM DTT, 0.2 mg/ml BSA, 0.02% TritonX-100, 20 mM Rb 2 SO 4 , 10 mM L-threonine, and 0.008 U/μl nicking enzyme.

17 . The method according to claim 15 , wherein the reaction catalysed by the nicking enzyme is part of or comprised within a nucleic acid amplification reaction.

18 . A reaction mixture for performing a reaction comprising the nicking of a double stranded oligonucleotide or polynucleotide substrate, the reaction mixture comprising: a nicking enzyme; a double stranded oligonucleotide or polynucleotide substrate; and a water-soluble rubidium salt in an effective amount to improve the activity of the nicking enzyme.

19 . The reaction mixture according to claim 18 , wherein the rubidium ion is present in solution at a concentration in the range 10-50 mM, more preferably 10-30 mM.

20 . The reaction mixture according to claim 18 , wherein the nicking enzyme is not a “V”-type nicking enzyme.

21 . The reaction mixture according to claim 18 , further comprising at least one buffer agent.

22 . The reaction mixture according to claim 18 , further comprising nucleotide triphosphates and a DNA polymerase.

23 . The reaction mixture according to claim 18 , other than a reaction mixture comprising 12.5 mM MgSO 4 , 90 mM Tris-HCl (pH 8.5), 15 mM NH 4 CH 3 CO 2 , 15 mM Na 2 SO 4 , 5 mM DTT, 0.2 mg/ml BSA, 0.02% Triton X-100, 20 mM Rb 2 SO 4 , 10 mM L-threonine, and 0.008 U/μl nicking enzyme.

24 . The reaction mixture according to claim 22 , wherein the DNA polymerase has strand-displacement activity.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2025
From: SHEN, DAIWEI; PEREZ, VICTOR; FARINA, ANTHONY; KRAYNACK, BRYAN
To: LUMIRADX INC.
Reel/Frame 072615/0772 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2025
From: LUMIRADX, INC.
To: LUMIRADX UK LTD.
Reel/Frame 072615/0908 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY, RECORDED ON MARCH 30, 2021 AT REEL/FRAME 055850/0771 Recorded Aug 5, 2024
From: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
To: LUMIRADX INTERNATIONAL LTD; LUMIRADX UK LTD
Reel/Frame 068327/0149 →
SECURITY INTEREST Recorded Aug 25, 2023
From: LUMIRADX INTERNATIONAL LTD; LUMIRADX UK LTD
To: BIOPHARMA CREDIT PLC
Reel/Frame 064709/0226 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2021
From: PROVINS, JARROD; PEREZ, VICTOR; SHEN, DAIWEI; FARINA, ANTHONY; KRAYNACK, BRYAN
To: LUMIRADX UK LIMITED
Reel/Frame 058380/0568 →